For the first time, Doctors Without Borders/Médecins Sans Frontières (MSF) is employing seasonal malaria chemoprevention (SMC) in Chad and Mali. 170,000 children aged between three months and five years received anti-malaria medicines during the peak transmission season. This treatment, recommended by the World Health Organization, will not eradicate malaria definitively. But in countries like Chad and Mali, where malaria is the first cause of infant and child mortality, it does have an important role to play in emergency situations.
Related News & Publications
Be part of MSF
Our supporters, donors, and fundraisers are a vital part of the MSF movement.
Find out how you can support MSF's lifesaving work.